Find Reports
Select Report Type
Reimbursement Review
Displaying 776 - 800 of 1258
Please scroll or swipe to the right to view the full content.
| Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|
| Jakavi | Ruxolitinib | Myelofibrosis | Reimburse with clinical criteria and/or conditions | Complete | PC0012-000 | |||
| Lodalis | Colesevelam hydrochloride | Hypercholesterolemia | Do not list at the submitted price | Complete | SR0274-000 | |||
| Zenhale | Mometasone/formoterol | Asthma | List with clinical criteria and/or conditions | Complete | SF0281-000 | |||
| Dificid | Fidaxomicin | Clostridium difficile infection | Do not list at the submitted price | Complete | SR0285-000 | |||
| Treanda | Bendamustine hydrochloride | Chronic Lymphocytic Leukemia (relapsed/refractory) | Do not reimburse | Complete | PC0011-000 | |||
| Treanda | Bendamustine hydrochloride | Non-Hodgkin Lymphoma and Mantle Cell Lymphoma | Reimburse | Complete | PC0010-000 | |||
| Votrient | Pazopanib Hydrochloride | Soft Tissue Sarcoma | Do not reimburse | Complete | PC0009-000 | |||
| Fampyra | Fampridine | Multiple sclerosis, improve walking disability | Do not list | Complete | SR0275-000 | |||
| Lucentis | Ranibizumab injection | Macular edema, secondary to retinal vein occlusion | List with clinical criteria and/or conditions | Complete | SR0276-000 | |||
| Toviaz | Fesoterodine fumarate | Overactive bladder | List in a similar manner | Complete | SR0277-000 | |||
| Xalkori | Crizotinib | Advanced Non-Small Cell Lung Cancer | Do not reimburse | Complete | PC0008-000 | |||
| Mozobil | Plerixafor | Hematopoietic stem cell mobilizer in non-Hodgkin's lymphoma and multiple myeloma | Do not list | Complete | SR0265-000 | |||
| Afinitor | Everolimus | Pancreatic Neuroendocrine Tumour | Reimburse with clinical criteria and/or conditions | Complete | PC0007-000 | |||
| Onbrez | Indacaterol | Chronic obstructive pulmonary disease | List in a similar manner | Complete | SR0273-000 | |||
| Xarelto | Rivaroxaban | Deep-vein thrombosis without symptomatic pulmonary embolism | List with clinical criteria and/or conditions | Complete | SR0271-000 | |||
| Rituxan | Rituximab | Granulomatosis with polyangiitis and microscopic polyangiitis | List with clinical criteria and/or conditions | Complete | SR0270-000 | |||
| Halaven | Eribulin Mesylate | Metastatic Breast Cancer | Reimburse with clinical criteria and/or conditions | Complete | PC0005-000 | |||
| Byetta | Exenatide | Diabetes mellitus, type 2 | Do not list | Complete | SR0246-000 | |||
| Resotran | Prucalopride | Constipation, chronic | Do not list | Complete | SR0266-000 | |||
| Botox | OnabotulinumtoxinA | Neurogenic detrusor overactivity | List with clinical criteria and/or conditions | Complete | SR0268-000 | |||
| Actemra | Tocilizumab | Arthritis, juvenile idiopathic | List with clinical criteria and/or conditions | Complete | SR0267-000 | |||
| Saphris | Asenapine | Schizophrenia | Do not list | Complete | SR0262-000 | |||
| Effient | Prasugrel | Acute coronary syndrome | Do not list | Complete | SR0263-000 | |||
| Eliquis | Apixaban | Venous thromboembolic events, prevention | List with clinical criteria and/or conditions | Complete | SR0264-000 | |||
| Saphris | Asenapine | Bipolar I disorder | List with clinical criteria and/or conditions | Complete | SR0262-001 |
Health Technology Review
Displaying 576 - 589 of 589
Horizon Scan
Displaying 101 - 111 of 111
Projects in Progress
Displaying 26 - 40 of 40
View All Reports
Displaying 776 - 800 of 2093
Please scroll or swipe to the right to view the full content.
| Title | Description | Files | Last Updated Sort ascending | Project Line | Project Sub Line | Status | Project Number |
|---|---|---|---|---|---|---|---|
| Assessment of Postoperative Vital Signs Frequency | Health Technology Review | Summary of Abstracts | Completed | RB1620-000 | |||
| Removable Rigid Dressings for the Post-Operative Management of Leg Amputations | Health Technology Review | Summary with Critical Appraisal | Completed | RC1432-000 | |||
| Private IV Infusion Clinics in Canada | Health Technology Review | Environmental Scan | Completed | ES0365-000 | |||
| Intranasal Glucagon for the Treatment of Hypoglycemia | Health Technology Review | Summary with Critical Appraisal | Completed | RC1435-000 | |||
| Ibrutinib for Chronic Graft versus Host Disease | Health Technology Review | Summary with Critical Appraisal | Completed | RC1433-000 | |||
| Formulary Management of Targeted Immune Modulators for Ulcerative Colitis | Health Technology Review | Technology Review | In Progress | HD0010-000 | |||
| CADTH Pharmaceutical Reviews Update — Issue 30 | Reimbursement Review | Pharmaceutical Review Update | |||||
| Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastric, Gastroesophageal Junction (GEJ), or Esophageal Cancer | Reimbursement Review | Provisional Funding Algorithm | Complete | PH0010-000 | |||
| Stereotactic Ablative Radiotherapy for the Treatment of Oligometastatic Cancer | Health Technology Review | Completed | HT0029-000/HT0029-004 | ||||
| tralokinumab | Reimbursement Review | Complete | SR0689-000 | ||||
| inclisiran | Reimbursement Review | Complete | SR0681-000 | ||||
| prasterone | Reimbursement Review | Complete | SR0707-000 | ||||
| Alpha1-proteinase inhibitor (Human) | Reimbursement Review | Complete | ST0702-000 | ||||
| Utilization of Cholinesterase Inhibitors for Alzheimer’s Disease in Canada | Health Technology Review | Technology Review | Completed | HC0027-000 | |||
| Self-Collection of Nose and Throat Swab Samples for SARS-CoV-2 Antigen Testing | Horizon Scan | Emerging Health Technologies | Completed | EH0109-000 | |||
| Utilization of Old versus New Generation Biologics for Public and Private Insurers in Canada | Health Technology Review | Technology Review | Completed | HC0020-000 | |||
| Dapagliflozin for Chronic Kidney Disease | Health Technology Review | Rapid Review with Expert Input | RD0065-000 | ||||
| Melatonin for the Treatment of Insomnia in Children and Adolescents | Health Technology Review | Rapid Review | Completed | RC1423-000 | |||
| pemigatinib | Reimbursement Review | Complete | PC0252-000 | ||||
| aducanumab | Reimbursement Review | Withdrawn | SR0705-000 | ||||
| Systemic Thrombolysis by Alteplase for Acute Ischemic Stroke | Health Technology Review | Rapid Review with Expert Input | Completed | RD0066-000 | |||
| Monitoring Patients With Psychotic Disorders for Clozapine-Induced Myocarditis or Cardiomyopathy | Health Technology Review | Rapid Review | RC1429-000 | ||||
| Guidelines for Pediatric Immune Thrombocytopenia | Health Technology Review | Rapid Review | RC1426-000 | ||||
| lorlatinib | Reimbursement Review | Complete | PC0249-000 | ||||
| CADTH Pharmaceutical Reviews Update — Issue 29 | Reimbursement Review | Pharmaceutical Review Update |